Clinical Neurology and Neurosurgery
Volume 111, Issue 10 , Pages 883-885 , December 2009

Ziprasidone-related oculogyric crisis in an adult

  • Bernardo de Mattos Viana

      Affiliations

    • Psychiatry Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais, Av. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte (MG), 30130-100, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 31 34099458; fax: +55 31 34099458.
    • ,
  • Hugo Alejandro Cano Prais

      Affiliations

    • Department of Medical Sciences, Federal University of Ouro Preto, Ouro Preto (MG), Brazil
    • ,
  • Sarah Teixeira Camargos

      Affiliations

    • Movement Disorders Clinic, Neurology Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais, Belo Horizonte (MG), Brazil
    • Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte (MG), Brazil
    • ,
  • Francisco Eduardo Costa Cardoso

      Affiliations

    • Movement Disorders Clinic, Neurology Service, Hospital das Clínicas (HC-UFMG), Federal University of Minas Gerais, Belo Horizonte (MG), Brazil
    • Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte (MG), Brazil

Received 23 December 2008 ,Revised 16 July 2009 ,Accepted 25 July 2009.

References 

  1. Janicak PG, Davis JM, Preskorn SH, Ayd Jr FJ, Marder SR, Pavuluri MN, editors. Treatment with antipsychotics. In: Principles and practice of psychopharmacotherapy. 4th edition Philadelphia: Lippincott Williams & Wilkins; 2006. p. 81–182.
  2. Sethi KD, Morgan JC. Drug-induced movement disorders. In:  Jankovic J,  Tolosa E editor. Parkinson's disease & movement disorders. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2007;p. 394–408
  3. Swett C. Drug-induced dystonia. Am J Psychiatry. 1975;132:532–534
  4. Owens DGC. Dystonia—a potential psychiatric pitfall. Br J Psychiatry. 1990;156:620–634
  5. Remington GJ, Voineskos G, Pollock B, Reed K, Coulter K. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia. Am J Psychiatry. 1990;147:1231–1233
  6. Ramos AE, Shytle RD, Silver AA, Sanberg PR. Ziprasidone-induced oculogyric crisis. J Am Acad Child Adolesc Psychiatry. 2003;42:1013–1014
  7. Gupta S, Nolan TN, Frank BL. Case report of oculogyric crisis with ziprasidone in a minor. Prim Care Companion J Clin Psychiatry. 2008;10:254–255
  8. Abe K. Psychiatric symptoms associated with oculogyric crisis: a review of literature for the characterization of antipsychotic-induced episodes. World J Biol Psychiatry. 2006;7:70–74
  9. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol. 1983;40:508–514
  10. Lee MS, Kim YD, Lyoo CH. Oculogyric crisis as an initial manifestation of Wilson's disease. Neurology. 1999;52:1714–1715
  11. Cardoso F, Eduardo C, Silva AP, Mota CC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997;12:701–703
  12. Jankovic J, Tolosa E. Parkinson's disease & movement disorders. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2007;
  13. Bogacz J, Bogacz D, Bogacz A. Oculomotor phenomena in petit-mal. Clin Neurophysiol. 2000;111:959–963
  14. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord. 2006;21:589–598
  15. FitzGerald P, Jankovic J. Tardive oculogyric crises. Neurology. 1989;39:1434–1437
  16. Sachdev P, Tardive . Chronically recurrent oculogyric crises. Mov Disord. 1993;8:93–97
  17. Bhoopathi PS, Soares-Weiser K. Benzodiazepines for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2003;(2):CD000205
  18. Reeves AL, So EL, Sharbrough FW, Krahn LE. Movement disorders associated with the use of gabapentin. Epilepsia. 1996;37:988–990
  19. Horiguchi J, Inami Y. Effect of clonazepam on neuroleptic-induced oculogyric crisis. Acta Psychiatr Scand. 1989;80:521–523
  20. Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD. The natural history of tardive dystonia, a long-term follow-up study of 107 cases. Brain. 1998;121:2053–2066
  21. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord. 1986;1:193–208
  22. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 1982;32:1335–1346
  23. Bilal L, Tsai C, Gasper JJ, Ndlela JC. Parkinsonism with intramuscular ziprasidone. Am J Psychiatry. 2005;162:2392–2393
  24. Mason MN, Johnson CE, Piasecki M. Ziprasidone-induced acute dystonia. Am J Psychiatry. 2005;162:625–626
  25. Weinstein SK, Adler CM, Strakowski SM. Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder. J Clin Psychiatry. 2006;67:327–328
  26. Mellacheruvu S, Norton JW, Schweinfurth J. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports. J Clin Psychopharmacol. 2007;27:206–207
  27. Keck ME, Müller MB, Binder EB, Sonntag A, Holsboer F. Ziprasidone-related tardive dyskinesia. Am J Psychiatry. 2004;161:175–176
  28. Papapetropoulos S, Wheeler S, Singer C. Tardive dystonia associated with ziprasidone. Am J Psychiatry. 2005;162:2191
  29. Tsai CS, Lee Y, Chang YY, Lin PY. Ziprasidone-induced tardive laryngeal dystonia: a case report. Gen Hosp Psychiatry. 2008;30:277–279
  30. Rosenquist KJ, Walker SS, Ghaemi SN. Tardive dyskinesia and ziprasidone. Am J Psychiatry. 2002;159:1436
  31. Ananth J, Burgoyne KS, Niz D, Smith M. Tardive dyskinesia in 2 patients treated with ziprasidone. J Psychiatry Neurosci. 2004;29:467–469

PII: S0303-8467(09)00187-5

doi: 10.1016/j.clineuro.2009.07.015

Clinical Neurology and Neurosurgery
Volume 111, Issue 10 , Pages 883-885 , December 2009

Article Tools